Clinical Trials Directory

Trials / Completed

CompletedNCT03258164

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

Fat Transplantation Enriched With Expanded Adipose-derived Autologous Mesenchymal Stromal Cells in Cosmetic Breast Augmentation and Cosmetic Facial Filling

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Stemform · Industry
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the present study is to examine whether enrichment of a fat graft with autologous ex vivo expanded ASC injected into the breast tissue or face, both for cosmetic use, will significantly improve the results of conventional lipofilling and synthetic facial fillers, thereby being able to offer a safer, more natural and long-lasting alternative to current artificial solutions for cosmetic patients.

Detailed description

The cosmetic breast augmentation design is a double-blind (surgeon and data assessor) randomized, prospective clinical study on healthy subjects. The cosmetic facial filling design is a data assessor-blinded, randomized, prospective clinical study on healthy subjects.

Conditions

Interventions

TypeNameDescription
BIOLOGICALASC enriched lipofillingFat grafts enriched with ex vivo expanded ASC
BIOLOGICALStandard LipofillingNon-ASC enriched fat grafts

Timeline

Start date
2017-03-22
Primary completion
2022-10-24
Completion
2022-11-22
First posted
2017-08-23
Last updated
2022-11-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03258164. Inclusion in this directory is not an endorsement.